United States · FDA National Drug Code directory

Levothyroxine Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50090-6984_0ea7070d-3328-482d-8801-96ad5a86ce59
Product NDC
50090-6984
Form
TABLET
Composition / generic term
Levothyroxine Sodium
Labeler
A-S Medication Solutions
Marketing category
ANDA
Marketing start / end (source format)
20190320
Source listing expiry
20261231

Source-listed ingredients

  • LEVOTHYROXINE SODIUM — .088 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 90 TABLET in 1 BOTTLE (50090-6984-0) · 50090-6984-0

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →